JP2023535620A5 - - Google Patents
Info
- Publication number
- JP2023535620A5 JP2023535620A5 JP2023505948A JP2023505948A JP2023535620A5 JP 2023535620 A5 JP2023535620 A5 JP 2023535620A5 JP 2023505948 A JP2023505948 A JP 2023505948A JP 2023505948 A JP2023505948 A JP 2023505948A JP 2023535620 A5 JP2023535620 A5 JP 2023535620A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2011871.7 | 2020-07-30 | ||
| GBGB2011871.7A GB202011871D0 (en) | 2020-07-30 | 2020-07-30 | Composition and method |
| PCT/GB2021/051985 WO2022023773A1 (en) | 2020-07-30 | 2021-07-30 | Composition and method |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023535620A JP2023535620A (ja) | 2023-08-18 |
| JP2023535620A5 true JP2023535620A5 (https=) | 2024-08-07 |
| JPWO2022023773A5 JPWO2022023773A5 (https=) | 2024-08-07 |
| JP7841821B2 JP7841821B2 (ja) | 2026-04-07 |
Family
ID=72425275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505948A Active JP7841821B2 (ja) | 2020-07-30 | 2021-07-30 | 組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230295237A1 (https=) |
| EP (1) | EP4188940A1 (https=) |
| JP (1) | JP7841821B2 (https=) |
| KR (1) | KR20230041820A (https=) |
| CN (1) | CN116406427A (https=) |
| AU (1) | AU2021319154A1 (https=) |
| BR (1) | BR112023001611A2 (https=) |
| CA (1) | CA3190289A1 (https=) |
| GB (1) | GB202011871D0 (https=) |
| WO (1) | WO2022023773A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202022002866U1 (de) | 2021-04-01 | 2024-03-20 | The Regents Of The University Of California | Genetische Modifikation von Säugetierzellen zur Verleihung von Resistenz gegen CSF1R-Antagonisten |
| CA3254570A1 (en) * | 2022-03-24 | 2023-09-28 | Capsida, Inc. | ADENE-ASSOCIATED VIRUS COMPOSITIONS WITH INCREASED CARDIAC ENRICHEMENT |
| AU2023267474A1 (en) * | 2022-05-13 | 2024-12-05 | Children's Medical Research Institute | Adeno-associated virus capsids |
| US20260108560A1 (en) * | 2022-07-13 | 2026-04-23 | The Regents Of The University Of California | Transplanting stem cell-derived microglia to treat leukodystrophies |
| CN121311596A (zh) * | 2023-04-07 | 2026-01-09 | 4D分子治疗有限公司 | 用于治疗补体病症的aav变体 |
| CN118480097B (zh) * | 2023-09-20 | 2024-11-05 | 广州派真生物技术有限公司 | 腺相关病毒突变体及其应用 |
| CN117660370B (zh) * | 2023-11-08 | 2025-03-21 | 中国人民解放军空军军医大学 | 一种重组腺相关病毒、抗炎药物及其在脓毒性脑病治疗中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9585971B2 (en) * | 2013-09-13 | 2017-03-07 | California Institute Of Technology | Recombinant AAV capsid protein |
| KR102423442B1 (ko) * | 2015-12-11 | 2022-07-20 | 캘리포니아 인스티튜트 오브 테크놀로지 | 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드 |
| JP7221275B2 (ja) * | 2017-08-03 | 2023-02-13 | ボイジャー セラピューティクス インコーポレイテッド | Ａａｖを送達するための組成物および方法 |
| US20210277418A1 (en) * | 2018-08-03 | 2021-09-09 | Voyager Therapeutics, Inc. | Aav variants with enhanced tropism |
-
2020
- 2020-07-30 GB GBGB2011871.7A patent/GB202011871D0/en not_active Ceased
-
2021
- 2021-07-30 CA CA3190289A patent/CA3190289A1/en active Pending
- 2021-07-30 AU AU2021319154A patent/AU2021319154A1/en active Pending
- 2021-07-30 JP JP2023505948A patent/JP7841821B2/ja active Active
- 2021-07-30 BR BR112023001611A patent/BR112023001611A2/pt unknown
- 2021-07-30 US US18/007,378 patent/US20230295237A1/en active Pending
- 2021-07-30 EP EP21756024.2A patent/EP4188940A1/en active Pending
- 2021-07-30 KR KR1020237007325A patent/KR20230041820A/ko active Pending
- 2021-07-30 WO PCT/GB2021/051985 patent/WO2022023773A1/en not_active Ceased
- 2021-07-30 CN CN202180066253.7A patent/CN116406427A/zh active Pending